4//SEC Filing
Loberg Philip Walden Jr 4
Accession 0000885590-11-000037
CIK 0000885590other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 2:52 PM ET
Size
5.3 KB
Accession
0000885590-11-000037
Insider Transaction Report
Form 4
Loberg Philip Walden Jr
EVP, Interim CFO
Transactions
- Purchase
Common Stock, no par value
2011-06-09$52.82/sh+7,500$396,150→ 137,565 total
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.64 to $53.00, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]This number includes 20,694 Performance based Restricted Share Units that were previously reported in Table I.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001508799
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 2:52 PM ET
- Size
- 5.3 KB